Table S3. Risk of events by Omega-3 Index modified to include docosapentaenoic acid (n = 2500).

	Hazard ratios (95% CIs
	Total CVD	Total CHD	Total stroke	Any mortality
Omega-3 Index–adjusted
<4.2% (n = 508)	1.0	1.0	1.0	1.0
4.2%–4.9% (n = 500)	1.06 (0.69, 1.63)	1.05 (0.60, 1.83)	1.16 (0.60, 2.24)	0.74 (0.53, 1.04)
4.9%–5.7% (n = 501)	1.10 (0.72, 1.68)	0.81 (0.44, 1.48)	1.30 (0.68, 2.49)	0.67 (0.46, 0.96) *
5.7%–6.8% (n = 502)	0.74 (0.47, 1.17)	0.63 (0.34, 1.20)	0.59 (0.28, 1.25)	0.59 (0.41, 0.86) †
>6.8% (n = 489)	0.61 (0.37, 0.99) *	0.58 (0.29, 1.18)	0.45 (0.20, 1.03)	0.66 (0.45, 0.96) *
P-value for linear trend	.008 †	.03 *	.006 †	.02 *
Modified Omega-3 Index (+DPA)–adjusted
<6.7% (n = 510)	1.0	1.0	1.0	1.0
6.7%–7.5% (n = 497)	1.01 (0.66, 1.54)	0.93 (0.54, 1.61)	1.04 (0.52, 2.07)	0.75 (0.53, 1.06)
7.5%–8.4% (n = 502)	0.83 (0.54, 1.27)	0.58 (0.32, 1.05)	1.09 (0.57, 2.08)	0.48 (0.40, 0.84) †
8.4%–9.7% (n = 507)	0.69 (0.44, 1.08)	0.54 (0.29, 1.01)	0.65 (0.31, 1.35)	0.72 (0.50, 1.04)
>9.7% (n = 484)	0.64 (0.40, 1.03)	0.54 (0.27, 1.05)	0.51 (0.23, 1.14)	0.61 (0.41, 0.90) *
P-value for linear trend	.012 *	.013 *	.024 *	.02 *

CVD, cardiovascular disease; CHD, coronary heart disease; CI, confidence interval.

^*P < .05

^†P < .01

^‡P < .001.

All significant hazard ratios/P-values are shown in bold italics.

Adjusted for all variables in Table 1.